HomeAbout PERSConduct DisorderThe PERS studyPatients and relativesResources
Members
Resources Publications

Publications

2010
2011
2012
2013
Accepted
Submitted

 

2010

Bobes, J.; Arango, C.; García-García, M.; Rejas, J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophrenia Research, 119(1-3):101-109, 2010.
Pubmed ID:20219322

Moreno, C.; Merchán-Naranjo, J.; Álvarez, M.; Baeza, I.; Alda, JA.; Martínez-Cantarero, C.; Parellada, M.; Sánchez, B.; de la Serna, E.; Giráldez, M.; Arango, C. Metabolic effects of second-generation antipsychotics in bipolar youth: Comparison with other psychotic and non-psychotic diagnoses. Bipolar Disorders, 12(2):172-84, 2010.
http://www.ncbi.nlm.nih.gov/pubmed?term=20402710


Rothenberger A, Gerlach M, Dittmann RW. Psychotropic drugs in child and adolescent psychiatry--a new era at the horizon. Curr Pharm Des.16(22):2395-7. 2010.
Pubmed ID:20513224


Top

2011

Arango, C.; Julio Bobes, J.; Kirkpatrick, B.; Garcia-Garcia, M.; Rejas, J. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study. European Neuropsychopharmacology. 2011.
Pubmed ID:21477998


Bobes, J.; Arango, C.; Aranda, P.; Carmena, R.; García-García, M.; Rejas, J.; on behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study. European Psychiatry. 2011.
Pubmed ID:21036549


Buitelaar JK.: About breaking barriers, the risk paradox, and other twists. Eur Child Adolesc Psychiatry 20(6):277-8. 2011.
Pubmed ID:21584709

Cuerda, C.; Merchan-Naranjo, J.; Velasco, C.; Gutierrez, A.; Leiva, M.; de Castro MJ.; Parellada, M.; Giráldez, M.; Bretón, I.; Camblor, M.; García-Peris, P.; Dulín, E.; Sanz, I.; Desco, M.; Arango, C. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics. Clinical Nutrition. 2011.
Pubmed ID:21492975


Drent, C.H.; Lettinga, J.R.; Buitelaar, J.K.; Glennon, J.C.; Hoekstra, P.J.: Risperidone-Induced Adverse Reactions in Children and Adolescents: A Literature Overview. Child and Adolescent Psychopharmacology News: Vol. 16, No. 6, pp. 10-11,13-14,16. 2011

Fraguas, D.; Correll, CU.; Merchán-Naranjo, J.; Rapado-Castro, M.; Parellada, M.; Moreno, C.; Arango, C. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo controlled comparisons. European Neuropsychopharmacology, 2011
Pubmed ID:20702068


Fraguas, D.; Parellada, M.; Moreno, D.; Arango, C. Quetiapine treatment in adolescents: A 6-month naturalistic study. Revista de Psiquiatría y Salud Mental, 3(3): 106-110, 2011.
Pubmed ID:23445997


Hoekstra PJ, Troost PW, Lahuis BE, Mulder H, Mulder EJ, Franke B, Buitelaar JK, Anderson GM, Scahill L, Minderaa RB.: Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene. J Child Adolesc Psychopharmacol.20(6):473-7. 2010.
Pubmed ID:21186965


Lettinga, J.R.; Drent, C.; Hoekstra, P.J.; Buitelaar, J.K.; Glennon, J.C.: Clinical Pharmacology of Conduct Disorder: A Critical Review. Child and Adolescent Psychopharmacology News: Vol. 16, No. 6, pp. 1-10. 2011


Robles, O.; Zabala, A.; Bombín, I.; Parellada, M.; Moreno, D.; Ruiz-Sancho, A.; Arango, C. Cognitive Efficacy of Quetiapine and Olanzapine in Early-Onset First-Episode Psychosis. Schizophrenia Bulletin, 37(2):405-15, 2011
Pubmed ID:19706697



Scheepers FE, Buitelaar JK, Matthys W.: Conduct Disorder and the specifier callous and unemotional traits in the DSM-5. Eur Child Adolesc Psychiatry 20(2):89-93. 2011.
Pubmed ID:21140182


Zuddas A, Zanni R, Usala T.: Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies. Eur Neuropsychopharmacol. Aug;21(8):600-20. 2011.
Pubmed ID:21550212


Top


2012

de Kuijper G.; Evenhuis H.; Minderaa R.B.; Hoekstra P.J.: Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. J Intellect Disabil Res. 2012 [Epub ahead of print]
Pubmed ID:23046144



Peyre H, Speranza M, Cortese S, Wohl M, Purper-Ouakil D. Do ADHD Children With and Without Child Behavior Checklist-Dysregulation Profile Have Different Clinical Characteristics, Cognitive Features, and Treatment Outcomes? J Atten Disord. Jul 26. 2012.
Pubmed ID:22837549


Porfirio MC, Lo-Castro A, Giana G, Giovinazzo S, Purper Ouakil D, Galasso C, Curatolo P. Attention-deficit hyperactivity disorder and binge eating disorder in a patient with 2q21.1-q22.2 deletion. Psychiatr Genet. Apr 27; 2012.
Pubmed ID:22517382

Saïas T, Lerner E, Greacen T, Simon-Vernier E, Emer A, Pintaux E, Guedeney A, Dugravier R, Tereno S, Falissard B, Tubach F. CAPEDP Study Group, Revah-Levy A. Evaluating fidelity in home-visiting programs a qualitative analysis of 1058 homevisit case notes from 105 families. PLoS One;7(5):e36915. 2012.
Pubmed ID:22629341


Tubach F, Greacen T, Saïas T, Dugravier R, Guedeney N, Ravaud P, Tereno S, Tremblay R, Falissard B, Guedeney A. CAPEDP Study Group. A home-visiting intervention targeting determinants of infant mental health: the study protocol for the CAPEDP randomized controlled trial in France. BMC Public Health;12:648. 2012.
Pubmed ID:22888979


Zuddas A. A crucial role for basic emotion awareness in the development of emotion regulation? Eur Child Adolesc Psychiatry.21(6):297-9. 2012.
Pubmed ID:22610086


Top


2013

Bons D, van den Broek E, Scheepers F, Herpers P, Rommelse N, Buitelaar JK.: Motor, emotional, and cognitive empathy in children and adolescents with autism spectrum disorder and conduct disorder. J Abnorm Child Psychol. 41(3):425-43. 2013.
Pubmed ID:23096764


Buitelaar, JK, Smeets, KC, Herpers, P, Scheepers, F, Glennon, J, Rommelse, N.N.J.: Conduct Disorders. Eur Child Adolesc Psychiatry, 22 (Suppl 1):S49–S54. 2013.
Pubmed ID:23224151


de Kuijper G, Mulder H, Evenhuis H, Scholte F, Visser F, Hoekstra P.J:. Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics. Res Dev Disabil. 34(9):2799-809.
Pubmed ID:23792429


de Kuijper G, Mulder H, Evenhuis H, Visser F, Hoekstra PJ. Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability. J Clin Psychopharmacol. 33(4):520-4. 2013.
Pubmed ID:23775048


de Kuijper GM, Mulder H, Evenhuis H, Visser F, Hoekstra PJ.: Effects of Discontinuation of Long-Term Used Antipsychotics on Prolactin and Bone Turnover Markers in Patients With Intellectual Disability. J Clin Psychopharmacol. 2013 [Epub ahead of print]
Pubmed ID:24135841



de Kuijper G, Mulder H, Evenhuis H, Scholte F, Visser F, Hoekstra PJ.: Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics. Res Dev Disabil. 34(9):2799-809. 2013
Pubmed ID:
23792429


de Kuijper G, Mulder H, Evenhuis H, Visser F, Hoekstra P.J.: Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability. J Clin Psychopharmacol. 33(4):520-4. 2013
Pubmed ID:
23775048


Dugravier R, Tubach F, Saias T, Guedeney N, Pasquet B, Purper-Ouakil D, Tereno S, Welniarz B, Matos J: CAPEDP study group, Guedeney A, Greacen T. Impact of a Manualized Multifocal Perinatal Home-Visiting Program Using Psychologists on Postnatal Depression: The CAPEDP Randomized Controlled Trial. PLoS One 19;8(8):e72216. 2013
Pubmed ID:23977257


Fliers EA, Buitelaar JK, Maras A, Bul K, Höhle E, Faraone SV, Franke B, Rommelse NN. ADHD is a risk factor for overweight and obesity in children. J Dev Behav Pediatr. 34(8):566-74. 2013.
Pubmed ID:24131879

Forgeot D'Arc B, Cortese S, Pinabel F, Purper-Ouakil D. Manifest for evidence-based child psychiatry in France. Eur Child Adolesc Psychiatry;
22(1):53-4. 2013.
Pubmed ID:22983530


Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, Hartman CA, Luman M, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry.203(2):112-9. 2013.
Pubmed ID:23846996


Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study. Addiction 108(8):1503-11. 2013
Pubmed ID:23506232


Hamshere ML, Langley K, Martin J, Agha SS, Stergiakouli E, Anney RJ, Buitelaar J, Faraone SV, Lesch KP, Neale BM, Franke B, Sonuga-Barke E, Asherson P, Merwood A, Kuntsi J, Medland SE, Ripke S, Steinhausen HC, Freitag C, Reif A, Renner TJ, Romanos M, Romanos J, Warnke A, Meyer J, Palmason H, Vasquez AA, Lambregts-Rommelse N, Roeyers H, Biederman J, Doyle AE, Hakonarson H, Rothenberger A, Banaschewski T, Oades RD, McGough JJ, Kent L, Williams N, Owen MJ, Holmans P, O'Donovan MC, Thapar A. High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry;170(8):909-16. 2013
Pubmed ID:23599091


Hoekstra PJ, Buitelaar JK: It is time for a harmonized ethical review procedure across Europe? Eur Child Adolesc Psychiatry 22(10):587-8. 2013.
Pubmed ID:24013351


Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong IC.: Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology (Berl). 2013 [Epub ahead of print]
Pubmed ID:24005531


Marsman R, Oldehinkel AJ, Ormel J, Buitelaar JK. The dopamine receptor D4 gene and familial loading interact with perceived parenting in predicting externalizing behavior problems in early adolescence: the TRacking Adolescents' Individual Lives Survey (TRAILS). Psychiatry Res.;209(1):66-73. 2013.
Pubmed ID:23246383


Mota NR, Bau CH, Banaschewski T, Buitelaar JK, Ebstein RP, Franke B, Gill M, Kuntsi J, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant JA, Sonuga-Barke EJ, Steinhausen HC, Faraone SV, Asherson P. Association between DRD2/DRD4 interaction and conduct disorder: a potential developmental pathway to alcohol dependence. Am J Med Genet B Neuropsychiatr Genet; 162B(6):546-9. 2013
Pubmed ID:23818181


Roke Y, van Harten PN, Franke B, Galesloot TE, Boot AM, Buitelaar JK. The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys. Pharmacogenet Genomics;23(9):487-93. 2013
Pubmed ID:23851570

Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J: European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry;170(3):275-89. 2013
Pubmed ID:23360949


Top


Accepted articles

Glennon J., Purper-Ouakil D., Bakker M., Zuddas A., Hoekstra P.J., Schulze U., Castro-Fornieles J., Santosh P.J., Arango C., Kölch M., Coghill D., Flamarique I., Penzol M.J.,Wan M., Murray M., Wong I.C.K., Danckaerts M., Bonnot O., Falissard B., Masi G.,Fegert J.M., Vicari S., Carucci S., Dittmann R.W., Buitelaar J.K., and the PERS Consortium: Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. European Child & Adolescent Psychiatry 2013
[Epub ahead of print]


Submitted articles

Schweren LJS, Hartman CA, Zwiers MP, Heslenfeld DJ, van der Meer D, Franke B, Oosterlaan J, Buitelaar J, Hoekstra PJ: Structural brain correlates of combined stimulant and atypical antipsychotic treatment in adolescents with Attention-Deficit/Hyperactivity Disorder. Submitted to JAACAP.

Top